In July 2025, Vertex Pharmaceuticals Incorporated conducted a study is to evaluate the pharmacokinetics, safety, tolerability ...

Vertex Pharmaceuticals (VRTX) received a significant boost as Health Canada's approval of ALYFTREK marked a vital step in expanding cystic fibrosis treatment options. This approval and other successes ...

The NHS will offer a once-daily triple therapy for cystic fibrosis to hundreds more patients, including those with rare ...

About a third of lung transplant patients with cystic fibrosis receive elexacaftor-tezacaftor-ivacaftor; use is higher among ...

At 7 years old, Morgan Barrett was diagnosed with cystic fibrosis. Prior to her diagnosis, she struggled to gain weight ...

Vertex Pharmaceuticals today announced that Health Canada has granted Marketing Authorization for PrALYFTREKTM (vanzacaftor/tezacaftor/deutivacaftor), a new triple combination therapy for patients ...

Reimbursement authority NICE has backed routine NHS use of Vertex's once-daily triple therapy Alyftrek ...

Only one doctor had ever mentioned the idea that Wright might have cystic fibrosis – which Wright had never heard of – but quickly dismissed the idea because, he said, Black people didn't get it.

Cystic fibrosis miracle drug Trikafta, helps 90% of people, the other 10% are still waiting for their aid. The small box full of promises arrived at Jessica Anderson’s home on her 31st birthday ...

One cystic fibrosis specialist told me about a patient in her 40s who finally decided to get braces to straighten crooked teeth and another who was planning a long-delayed cosmetic procedure on ...

Charles Kim Haskell told Newsweek he once thought he wouldn't live beyond his teenage years, but, at 31, he is enjoying his life.